Obelisk is a pioneering brand dedicated to tackling childhood obesity in Europe through innovative insights and strategies. With a focus on prevention, Obelisk aims to understand, predict, and prevent obesity in children while providing precision medicine for those affected. The brand's 4P's approach involves active participation from stakeholders such as families, scientific and medical communities, schools, policymakers, and industry to drive social innovation and achieve successful outcomes.

Through a research program implemented by a consortium of 15 partners across Europe, Obelisk aims to develop evidence-based clinical guidelines, best practices, and preventive strategies to combat childhood overweight and obesity effectively. By utilizing predictive tools and targeted prevention strategies, Obelisk empowers patients and clinicians to make informed decisions on interventions for controlling the progression of obesity in children, leading to improved health outcomes and quality of life for affected individuals. With a mission to decrease rates of childhood obesity and increase successful treatment outcomes, Obelisk is at the forefront of fighting this critical health issue.